Histogenics Quote - HSGX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.162

Bid

0.164

Ask

0.166

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

41.553M

Previous Close

0.162

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

256,502,000

Dividend Yield

PE Ratio

-3.05

Earnings Per Share (EPS)

-0.25

Revenue

6.04M

Net Profit

-63.08M

Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to tre... Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. Histogenics operates in two geographic regions: The United States (Massachusetts) and Israel (Tel Aviv). Regenerative medicine technologies encompass a variety of therapeutic approaches, including tissue engineering, cell-based therapies, gene therapy, small molecules and biologics, stem cells and biobanking. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Ortho,prosth,surg Appl,suply

Website

ocugen.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

BOSTON and JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan...

Histogenics Corporation Announces Approval of Merger by Stockholders at Special Meeting

BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that all proposals related to its proposed merger with Ocugen...

Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019

BOSTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it convened and then adjourned, without conducting any...

Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting

BOSTON, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it intends to convene and then adjourn, without conducting...

Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel...

BOSTON, Mass. and MALVERN, Penn., April 08, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a privately held clinical-stage biopharmaceutical company focused...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

HSGX - Frequently Asked Questions (FAQ)

What is the current Histogenics share price?

The current share price of Histogenics is US$ 0.162

How many Histogenics shares are in issue?

Histogenics has 256,502,000 shares in issue

What is the market cap of Histogenics?

The market capitalisation of Histogenics is USD 41.55M

What is the 1 year trading range for Histogenics share price?

Histogenics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Histogenics?

The price to earnings ratio of Histogenics is -3.05

What is the cash to sales ratio of Histogenics?

The cash to sales ratio of Histogenics is 31.91

What is the reporting currency for Histogenics?

Histogenics reports financial results in USD

What is the latest annual turnover for Histogenics?

The latest annual turnover of Histogenics is USD 6.04M

What is the latest annual profit for Histogenics?

The latest annual profit of Histogenics is USD -63.08M

What is the registered address of Histogenics?

The registered address for Histogenics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Histogenics website address?

The website address for Histogenics is ocugen.com

Which industry sector does Histogenics operate in?

Histogenics operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
IPAImmunoPrecise Antibodies Ltd	US$ 0.7668 (55.54%)	11.88M
DXRDaxor Corporation	US$ 11.88 (44.56%)	8
NEHCNew Era Helium Inc	US$ 3.95 (44.16%)	1.49M
ADAGAdagene Inc	US$ 2.50 (41.08%)	3
ASSTAsset Entities Inc	US$ 1.23 (36.67%)	8.15M
ABLAbacus Life Inc	US$ 3.01 (-59.97%)	31
RMBIRichmond Mutual Bancorporation Inc	US$ 8.01 (-40.31%)	1
IZTCInvizyne Technologies Inc	US$ 7.02 (-37.88%)	7
GLACGlobal Lights Acquisition Corporation	US$ 7.30 (-31.78%)	6
ARTVArtiva Biotherapeutics Inc	US$ 5.31 (-24.89%)	2
IPAImmunoPrecise Antibodies Ltd	US$ 0.7668 (55.54%)	11.88M
CDIOCardio Diagnostics Holdings Inc	US$ 0.8157 (34.16%)	8.25M
ASSTAsset Entities Inc	US$ 1.23 (36.67%)	8.15M
RIMEAlgorhythm Holdings Inc	US$ 0.038 (9.83%)	7.08M
SHViShares Short Treasury Bond ETF	US$ 110.365 (0.01%)	3.56M